Myongji Hospital
| Republic of Korea | Thailand | Turkey | |
| Coronary bypass surgery | - | from AUD $34,898 | from AUD $18,845 |
No hidden fees – just official clinic prices. Pay at the clinic for Coronary bypass surgery upon arrival and use a flexible instalment plan if needed.
Bookimed is committed to your safety. We only work with medical institutions that maintain high international standards in Coronary bypass surgery and have the necessary licenses to serve international patients worldwide.
Bookimed offers free expert assistance. A personal medical coordinator supports you before, during, and after your treatment, solving any issues. You're never alone on your Coronary bypass surgery journey.
Dr. Ahn Taehun is a cardiologist (MD, PhD) and Director of a Cardiovascular Center. He specializes in coronary artery disease, including angina and myocardial infarction. He also treats hypertension, heart valve disease, heart failure, and hyperlipidemia. His expertise includes interventional cardiology, echocardiography, and cardiovascular imaging. He also manages atherosclerosis, arterial occlusive disease, dilated cardiomyopathy, and myocarditis.
He has held several leadership roles. He served as Chairman of the Board of the Korean Society of Interventional Cardiology (KSIC) and President of the Korean Society of Cardiology (KSC). He was Finance Director of the KSC. He led the Korean Vascular Intervention Society (KVIS) and the Korean Cardiovascular Complications Committee (KCCC) as President. He also chaired the Organizing Committee for ENCORE SEOUL (Endovascular & Coronary Revascularization).
Dr. Oh Dongju, MD, PhD, is a cardiologist. He specializes in hypertension, hyperlipidemia, angina, myocardial infarction, valvular disease, dilated cardiomyopathy, and myocarditis. His work also covers atherosclerosis and arterial occlusive disease. He is skilled in echocardiography and cardiovascular imaging.
He completed a cardiology fellowship at Emory University School of Medicine. He also served as a Clinical Instructor at the Cornell University Weill Department of Medicine. He has held many leadership roles. He served as President, KSIC; Director of Publications, General Affairs, and Public Relations, KSC; Chairman, KACG; Board Member, Asan Heart Foundation; Vice President, KHA; Chairman, Division of Cardiology, KAIM; Vice President, NAMOK/KAMS; Governor, ACC Korea Chapter; and Member, the National Bioethics Committee.
Professor Kim Ki-bong specializes in CABG, valve surgery, atrial fibrillation, and heart transplantation. He is Director of the Cardiac Surgery and Cardiovascular Centers at Myongji Hospital. He pioneered advanced coronary bypass in Korea. He has extensive OPCAB experience and works on the TECAB team using the da Vinci Xi.
In 2025, his team performed Korea’s first totally endoscopic CABG without cardiopulmonary bypass. In August 2026, they achieved the nation’s first multivessel TECAB.
He is former Chair of Thoracic and Cardiovascular Surgery at Seoul National University College of Medicine. He is also former Chief of the same department at Seoul National University Hospital. He serves on the Editorial Board of The Annals of Thoracic Surgery. He is a member of AATS, STS, and EACTS. He is a past President of the Korean Societies of Coronary Artery Surgery, Surgical Treatment of Arrhythmias, and Thoracic and Cardiovascular Surgery. His research includes 130+ international and 140+ Korean papers. He has given 80+ international and 80+ Korean lectures. He earned his MD, Master’s, and PhD at Seoul National University.